I agree that this site is using cookies. You can find further informations here.
X
Rampal, Raajit K
156  results:
Search for persons X
?
1

Mixed histiocytic neoplasms: A multicentre series revealing..:

Friedman, Joshua S. ; Durham, Benjamin H. ; Reiner, Anne S....
British Journal of Haematology.  205 (2024)  1 - p. 127-137 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Treatment approach and outcomes of patients with accelerate..:

Patel, Anand A. ; Yoon, James J. ; Johnston, Hannah...
Blood Advances.  8 (2024)  13 - p. 3468-3477 , 2024
Link: https://doi.org/10.1182/..
 
?
3

Phase 2 study of add-on parsaclisib for patients with myelo..:

Yacoub, Abdulraheem ; Borate, Uma ; Rampal, Raajit K....
Blood Advances.  8 (2024)  6 - p. 1515-1528 , 2024
Link: https://doi.org/10.1182/..
 
?
4

Interferons in the treatment of myeloproliferative neoplasm:

Vachhani, Pankit ; Mascarenhas, John ; Bose, Prithviraj...
Therapeutic Advances in Hematology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
5

S168: PELABRESIB (CPI-0610) MONOTHERAPY IN PATIENTS WITH HI..:

Passamonti, Francesco ; Patriarca, Andrea ; Knapper, Steven...
HemaSphere.  7 (2023)  S3 - p. e9927843 , 2023
Link: https://doi.org/10.1097/..
 
?
6

POSTER: MPN-439 Preliminary Data From the Phase 1/2 Study o..:

El Chaer, Firas ; Rein, Lindsay ; Shimoda, Kazuya...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S195 , 2023
Link: https://doi.org/10.1016/..
 
?
7

A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients w..:

Mascarenhas, John ; Migliaccio, Anna Rita ; Kosiorek, Heidi...
Clinical Cancer Research.  29 (2023)  18 - p. 3622-3632 , 2023
Link: https://doi.org/10.1158/..
 
?
8

P1018: UPDATED RESULTS FROM MANIFEST ARM 2: EFFICACY AND SA..:

Kremyanskaya, Marina ; Harrison, Claire ; Bose, Prithviraj...
HemaSphere.  7 (2023)  S3 - p. e0578580 , 2023
Link: https://doi.org/10.1097/..
 
?
9

P1031: PRELIMINARY DATA FROM THE PHASE 1/2 STUDY OF TP-3654..:

El Chaer, Firas ; Rein, Lindsay ; Shimoda, Kazuya...
HemaSphere.  7 (2023)  S3 - p. e42358df , 2023
Link: https://doi.org/10.1097/..
 
?
10

Outcomes after interruption of targeted therapy in patients..:

Reiner, Anne S. ; Durham, Benjamin H. ; Yabe, Mariko...
British Journal of Haematology.  203 (2023)  3 - p. 389-394 , 2023
Link: https://doi.org/10.1111/..
 
?
11

P1030: SPLEEN VOLUME REDUCTION PREDICTS SURVIVAL IN MYELOFI..:

Bewersdorf, Jan ; Ajufo, Helen ; Harrison, Claire...
HemaSphere.  7 (2023)  S3 - p. e44640da , 2023
Link: https://doi.org/10.1097/..
 
?
12

MPN-439 Preliminary Data From the Phase 1/2 Study of TP-365..:

El Chaer, Firas ; Rein, Lindsay ; Shimoda, Kazuya...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S395-S396 , 2023
Link: https://doi.org/10.1016/..
 
?
13

P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATE..:

Zaroogian, Zachary ; Adamczyk, Elżbieta ; Moszyńska, Adrianna...
HemaSphere.  7 (2023)  S3 - p. e133428d , 2023
Link: https://doi.org/10.1097/..
 
?
14

Matching-adjusted indirect comparison of the pelabresib-rux..:

Gupta, Vikas ; Mascarenhas, John ; Kremyanskaya, Marina...
Blood Advances.  7 (2023)  18 - p. 5421-5432 , 2023
Link: https://doi.org/10.1182/..
 
?
15

P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOL..:

Harrison, Claire ; Mascarenhas, John ; Cilloni, Daniela...
HemaSphere.  7 (2023)  S3 - p. e87048d4 , 2023
Link: https://doi.org/10.1097/..
 
1-15